This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Healthcare ETF (PTH) Hits New 52-Week High
by Sanghamitra Saha
The fund PTH hit a 52-week high on May 11. Can it sustain the rally?
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
High Momentum ETFs & Stocks to Bet on
by Sanghamitra Saha
These high-momentum ETFs and stocks could be good ways to play the latest optimism in the market.
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
by Sanghamitra Saha
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
US Economy in "Late-Cycle" Phase? ETFs to Play
by Sanghamitra Saha
U.S. economy is probably witnessing a mini-reflation wave within an ongoing late cycle, per some analysts. One can play the trend with these ETFs.
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks
by Sanghamitra Saha
Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.
Best June for Stocks in Decades: 5 Best ETFs
by Sweta Killa
We have presented a bunch of top-performing ETFs so far this month that will continue to outperform if the current trends continue.
5 Top Smart-Beta ETF Charts Amid Trade Tensions
by Sanghamitra Saha
About 58% asset owners have opted for smart beta products in 2019, an all-time high, per FTSE Russell. Let???s see which smart-beta ETFs have stood victorious in the latest round of trade turmoil.
ETF Winners & Losers of Last Week
by Sweta Killa
In the light of recent positive developments, here we highlight the best and the worst-performing ETFs to start June.
Healthcare and Mid-Cap: 2 ETFs to Watch on Outsized Volume
by Sweta Killa
PTH and IVOG saw massive trading volumes in yesterday trading session.